The gut microbiota-a clinical perspective on lessons learned

Typeset version

 

TY  - JOUR
  - Shanahan, F.
  - 2012
  - October
  - Nature Reviews Gastroenterology ; Hepatology
  - The gut microbiota-a clinical perspective on lessons learned
  - Validated
  - ()
  - 9
  - 1010
  - 609
  - 614609
  - Once considered obscure and largely ignored by microbiologists, the human microbiota has moved centre-stage in biology. The gut microbiota is now a focus of disparate research disciplines, with its contributions to health and disease ready for translation to clinical medicine. The changing composition of the microbiota is linked with changes in human behaviour and the rising prevalence of immunoallergic and metabolic disorders. The microbiota is both a target for drug therapy and a repository for drug discovery. Its secrets promise the realization of personalized medicine and nutrition, and will change and improve conventional dietary management.Once considered obscure and largely ignored by microbiologists, the human microbiota has moved centre-stage in biology. The gut microbiota is now a focus of disparate research disciplines, with its contributions to health and disease ready for translation to clinical medicine. The changing composition of the microbiota is linked with changes in human behaviour and the rising prevalence of immunoallergic and metabolic disorders. The microbiota is both a target for drug therapy and a repository for drug discovery. Its secrets promise the realization of personalized medicine and nutrition, and will change and improve conventional dietary management.
  - 1759-50451759-5045
  - ://WOS:000309592200008://WOS:000309592200008
DA  - 2012/10
ER  - 
@article{V235378895,
   = {Shanahan,  F. },
   = {2012},
   = {October},
   = {Nature Reviews Gastroenterology ; Hepatology},
   = {The gut microbiota-a clinical perspective on lessons learned},
   = {Validated},
   = {()},
   = {9},
   = {1010},
  pages = {609--614609},
   = {{Once considered obscure and largely ignored by microbiologists, the human microbiota has moved centre-stage in biology. The gut microbiota is now a focus of disparate research disciplines, with its contributions to health and disease ready for translation to clinical medicine. The changing composition of the microbiota is linked with changes in human behaviour and the rising prevalence of immunoallergic and metabolic disorders. The microbiota is both a target for drug therapy and a repository for drug discovery. Its secrets promise the realization of personalized medicine and nutrition, and will change and improve conventional dietary management.Once considered obscure and largely ignored by microbiologists, the human microbiota has moved centre-stage in biology. The gut microbiota is now a focus of disparate research disciplines, with its contributions to health and disease ready for translation to clinical medicine. The changing composition of the microbiota is linked with changes in human behaviour and the rising prevalence of immunoallergic and metabolic disorders. The microbiota is both a target for drug therapy and a repository for drug discovery. Its secrets promise the realization of personalized medicine and nutrition, and will change and improve conventional dietary management.}},
  issn = {1759-50451759-5045},
   = {://WOS:000309592200008://WOS:000309592200008},
  source = {IRIS}
}
AUTHORSShanahan, F.
YEAR2012
MONTHOctober
JOURNAL_CODENature Reviews Gastroenterology ; Hepatology
TITLEThe gut microbiota-a clinical perspective on lessons learned
STATUSValidated
TIMES_CITED()
SEARCH_KEYWORD
VOLUME9
ISSUE1010
START_PAGE609
END_PAGE614609
ABSTRACTOnce considered obscure and largely ignored by microbiologists, the human microbiota has moved centre-stage in biology. The gut microbiota is now a focus of disparate research disciplines, with its contributions to health and disease ready for translation to clinical medicine. The changing composition of the microbiota is linked with changes in human behaviour and the rising prevalence of immunoallergic and metabolic disorders. The microbiota is both a target for drug therapy and a repository for drug discovery. Its secrets promise the realization of personalized medicine and nutrition, and will change and improve conventional dietary management.Once considered obscure and largely ignored by microbiologists, the human microbiota has moved centre-stage in biology. The gut microbiota is now a focus of disparate research disciplines, with its contributions to health and disease ready for translation to clinical medicine. The changing composition of the microbiota is linked with changes in human behaviour and the rising prevalence of immunoallergic and metabolic disorders. The microbiota is both a target for drug therapy and a repository for drug discovery. Its secrets promise the realization of personalized medicine and nutrition, and will change and improve conventional dietary management.
PUBLISHER_LOCATION
ISBN_ISSN1759-50451759-5045
EDITION
URL://WOS:000309592200008://WOS:000309592200008
DOI_LINK
FUNDING_BODY
GRANT_DETAILS